Neurological Prognostication of Cardiac Arrest in an Era of Extracorporeal Membrane Oxygenation

Abstract

A neuron-specific enolase level greater than 33 ng/mL at days 1 to 3 or status myoclonus within 1 day are traditional indicators of poor neurological prognosis in survivors of cardiac arrest. We report the case of a 70-year-old man who received extracorporeal membrane oxygenation following cardiac arrest. Despite having both an elevated neuron-specific enolase concentration of 68 ng/mL and status myoclonus, he made an excellent neurological recovery. The value of traditional markers of poor prognosis such as elevated neuron-specific enolase or status myoclonus has not been systematically validated in patients treated with extracorporeal membrane oxygenation or therapeutic hypothermia. Straightforward application of practice guidelines in these cases may result in tragic outcomes. This case underscores the need for reliable prognostic markers that account for recent advances in cardiopulmonary and neurological therapies.

Keywords

neurocritical care clinical specialty prognosis coma neuron-specific enolase status myoclonus

Get full access to this article

View all access options for this article.

References

Wijdicks

EFM

Hijdra

Young

Bassetti

Wiebe

. Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006;67(2):203–210.

Blondin

Greer

. Neurologic prognosis in cardiac arrest patients treated with therapeutic hypothermia. Neurologist. 2011;17(5):241–248.

Floerchinger

Philipp

Foltan

. Neuron-specific enolase serum levels predict severe neuronal injury after extracorporeal life support in resuscitation. Eur J Cardiothorac Surg. 2014;45(3):496–501.

De Georgia

Raad

. Prognosis of coma after cardiac arrest in the era of hypothermia. Continuum (Minneap Minn). 2012;18(3):515–531.

Werhahn

Brown

Thompson

Marsden

. The clinical features and prognosis of chronic posthypoxic myoclonus. Mov Disord. 1997;12(2):216–220.

Byrnes

McKamie

Swearingen

. Hemolysis during cardiac extracorporeal membrane oxygenation: a case-control comparison of roller pumps and centrifugal pumps in a pediatric population. ASAIO J. 2011;57(5):456–461.

Steffen

Hasper

Ploner

. Mild therapeutic hypothermia alters neuron specific enolase as an outcome predictor after resuscitation: 97 prospective hypothermia patients compared to 133 historical non-hypothermia patients. Crit Care. 2010;14(2):r69.

Huntgeburth

Adler

Rosenkranz

. Changes in neuron-specific enolase are more suitable than its absolute serum levels for the prediction of neurologic outcome in hypothermia-treated patients with out-of-hospital cardiac arrest. Neurocrit Care. 2014;20(3):358–366.

Stammet

Collignon

Hassager

. Neuron-specific enolase as a predictor of death or poor neurological outcome after out-of-hospital cardiac arrest and targeted temperature management at 33°C and 36°C. J Am Coll Cardiol. 2015;65(19):2104–2114.

10.

Cronberg

Rundgren

Westhall

. Neuron-specific enolase correlates with other prognostic markers after cardiac arrest. Neurology. 2011;77(7):623–630.

11.

Mlynash

Buckwalter

Okada

. Serum neuron-specific enolase levels from the same patients differ between laboratories: assessment of a prospective post-cardiac arrest cohort. Neurocrit Care. 2013;19(2):161–166.

12.

Seder

Sunde

Rubertsson

. Neurologic outcomes and postresuscitation care of patients with myoclonus following cardiac arrest. Crit Care Med. 2015;43(5):965–972.

13.

Mateen

Muralidharan

Shinohara

Parisi

Schears

Wijdicks

. Neurological injury in adults treated with extracorporeal membrane oxygenation. Arch Neurol. 2011;68(12):1543–1549.

14.

Yuan

Xiao

. Changes and clinic research of neuron-specific enolase in acute cerebral hemorrhage. J Apoplexy Nerv Dis. 2004;2:002.